HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
NCT05190068
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
89
Enrollment
INDUSTRY
Sponsor class
Conditions
B-Cell Non-Hodgkin's Lymphoma
Interventions
DRUG:
HMPL-760
Sponsor
Hutchmed